openPR Logo
Press release

Immunoglobulin Market impact of drivers and challenges 2026 Baxter international Inc., CSL Ltd., Bayer Healthcare, Biotest AG, Grifols S.A, Kedrion Biopharma Inc.

02-12-2019 12:07 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Immunoglobulin Market

Immunoglobulin Market

Immunoglobulins are critical part of the immune response, which specifically recognize and bind to particular antigens such as bacteria or viruses aiding in their inhibition. Immunoglobulins also called as antibodies are the glycoprotein molecules produced by plasma cells i.e. white blood cells. The antibody immune response is highly complex and very specific. The various immunoglobulin classes and subclasses (isotypes) differ in their biological features, structure, target specificity and distribution. Hence, the assessment of the immunoglobulin isotype can provide useful insight into complex humoral immune response.

For In depth Information Get FREE Sample Copy of this Report at: https://www.coherentmarketinsights.com/insight/request-sample/1712

Immunoglobulin Market - Competitive Analysis

-Baxter international Inc.
-CSL Ltd.
-Grifols S.A
-Octapharma AG
-Kedrion Biopharma Inc.
-LFB group
-Biotest AG
-China Biologics Products, Inc.
-BDI Pharma Inc.
-Bayer Healthcare
-Hualan Biological Engineering Inc.
-Omrix Biopharmaceuticals Ltd.
-Behring GmbH
-Shanghai RAAS Blood Products Co., Ltd.
-Option Care Enterprises, Inc.
-ADMA Biologics, Inc.
-BioScrip, Inc.

Immunoglobulin manufactures are involved in research and development to develop new immunoglobulin drug. For instance, GigaGen received US$ 3 million grant from the National Institutes of Health in January 2018, to develop novel antibody therapies to advance its next-generation plasma therapy for patients with immune deficiencies

Evolve Biologics, a division of Therapure Biopharma Inc. in May 2018, announced the start of phase III clinical trial of PlasmaCap IG (Intravenous Immunoglobulin or “IVIG”). The PlasmaCap IG is an investigational IVIG replacement therapy being studied in both adult and pediatric patients with Primary Immune Deficiency Diseases (PIDD). More such ongoing clinical trials are supporting growth of the immunoglobulin market.

Immunoglobulin Market Taxonomy:

By Product:
-IgG
-IgA
-IgM
-IgE
-IgD

By Mode of Delivery:
-Intravenous
-Subcutaneous

By Region:
-North America
-Latin America
-Europe
-Asia Pacific
-Middle East
-Africa

There are different classes of immunoglobulin such as IgG, IgA, and IgM, which are used for the treatment of various immunological and neurological diseases. These immunoglobulins can be administered intravenously and subcutaneously.

Immunoglobulin are used in treatment of autoimmune diseases such as multiple sclerosis, Primary Humoral Immunodeficiency (PIDD), Immune Thrombocytopenia Purpura (ITP), and autoimmune haemolytic anemia. Furthermore, immunoglobulin have applications in various other field such as hematology, neurology, immunology, dermatology, ophthalmology, nephrology and rheumatology, which is driving growth of the immunoglobulin market.

Immunoglobulin Market Dynamics

Furthermore, increasing application of immunoglobulin is gaining significant traction among pharmaceutical and Biopharmaceuticals Company for the research and development of immunoglobulin. Moreover, increasing number of intravenous product approvals and clinical trials for new clinical applications is anticipated to provide potential growth opportunities to the industry. For instance, in May 2018, ADMA Biologics, Inc. announced that the company had received U.S. patent for treating respiratory infection. The patent consist of usage of polyclonal immunoglobulin preparation for treatment of respiratory infection, where the issued patent extends to January 2035.

Furthermore, Kedrioin Biopharma and Kamada Ltd. together in May 2018, launched two human-derived protein therapeutics companies announced that KEDRAB [Rabies Immune Globulin (Human)] has been launched in the U.S. as it has received U.S. Food and Drug Administration approval for passive, transient post-exposure prophylaxis of rabies infection, when given immediately after contact with a rabid or possibly rabid animal and concurrent with the rabies vaccine. Such advancement and launches in field of immunoglobulin are expected to foster growth of the immunoglobulin market in near future.

For More Details On this Report: https://www.coherentmarketinsights.com/ongoing-insight/immunoglobulin-market-1712

Increasing incidences of Primary Immunodeficiency Disease (PID) worldwide is also a major factor driving growth of the immunoglobulin market. As per Center for Disease Control and Prevention (CDC), in 2012, the incidence rate of hypogammaglobulinemia across the globe was around 2 per 100,000 populations annually and is expected to increase in near future. Furthermore, increasing number of geriatric population, which is more prone to develop disease due to low antibody immune response of body is propelling the demand for immunoglobulin. However, high cost of treatment, long-term side-effects, stringent regulatory framework, and emergence of alternative therapies such recombinant products are expected to restrain growth of the immunoglobulin market.

Immunoglobulin Market - Regional Insights

Geographically, global Immunoglobulin market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America accounted for the largest share in the immunoglobulin market, followed by Europe in 2016. This is attributed to increasing number of the U.S. Food and Drug Administration approval for immunoglobulin. For instance, in 2016, Shire plc. announced the launch of CUVITRU [Immune Globulin Subcutaneous (Human), 20% Solution] the first and only Subcutaneous 20% treatment option without proline available in the U.S. to treat adult and pediatric patients (two years of age and older) with primary immunodeficiency (PI).

Furthermore, several pharmaceutical and biotechnological companies from Asia Pacific are focusing on expanding in their products overall the globe. For instance, the South Korea’s Green Cross in November 2017, stated that the company expects to launch its immunodeficiency drugs in U.S. market in 2018, as company is been working with US FDA to prepare additional production-related data on its drug IVIG-SN, human normal immunoglobulin G for intravenous administration.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Immunoglobulin Market impact of drivers and challenges 2026 Baxter international Inc., CSL Ltd., Bayer Healthcare, Biotest AG, Grifols S.A, Kedrion Biopharma Inc. here

News-ID: 1580481 • Views: 630

More Releases from Coherent Market Insights

Cosmetic Dentistry Market Key Findings with Worldwide Top Companies Danaher Corp …
The Cosmetic Dentistry Market Report highlights key market elements, opportunities, regional market, emerging growth drivers, market challenges, forecasts and market share competitors. The key objective of the Cosmetic Dentistry Market Report is to provide an appropriate and strategic analysis of the Cosmetic Dentistry industry. The Cosmetic Dentistry Global Market Report provides forward-looking information on major and minor factors that may explode or limit market development. The Cosmetic Dentistry Markets Report provides
Thyroid Cancer Drugs Market Key Findings with Worldwide Top Companies Biovista, …
The Thyroid Cancer Drugs Market Report highlights key market elements, opportunities, regional market, emerging growth drivers, market challenges, forecasts and market share competitors. The key objective of the Thyroid Cancer Drugs Market Report is to provide an appropriate and strategic analysis of the Thyroid Cancer Drugs industry. The Thyroid Cancer Drugs Global Market Report provides forward-looking information on major and minor factors that may explode or limit market development. The Thyroid
Anti-body Coupled T Receptor Therapy Market Key Findings with Worldwide Top Comp …
The Anti-body Coupled T Receptor Therapy Market Report highlights key market elements, opportunities, regional market, emerging growth drivers, market challenges, forecasts and market share competitors. The key objective of the Anti-body Coupled T Receptor Therapy Market Report is to provide an appropriate and strategic analysis of the Anti-body Coupled T Receptor Therapy industry. The Anti-body Coupled T Receptor Therapy Global Market Report provides forward-looking information on major and minor factors
Remicade Biosimilars Market Key Findings with Worldwide Top Companies Janssen Bi …
The Remicade Biosimilars Market Report highlights key market elements, opportunities, regional market, emerging growth drivers, market challenges, forecasts and market share competitors. The key objective of the Remicade Biosimilars Market Report is to provide an appropriate and strategic analysis of the Remicade Biosimilars industry. The Remicade Biosimilars Global Market Report provides forward-looking information on major and minor factors that may explode or limit market development. The Remicade Biosimilars Markets Report provides

All 5 Releases


More Releases for Immunoglobulin

Immunoglobulin Market Opportunity Analysis, 2018-2026
Immunoglobulins are critical part of the immune response, which specifically recognize and bind to particular antigens such as bacteria or viruses aiding in their inhibition. Immunoglobulins also called as antibodies are the glycoprotein molecules produced by plasma cells i.e. white blood cells. The antibody immune response is highly complex and very specific. The various immunoglobulin classes and subclasses (isotypes) differ in their biological features, structure, target specificity and distribution. Hence,
Intravenous Immunoglobulin (IVIg) Market Promising Growth Opportunities over 202 …
The term “immunoglobulin” refers to the breakdown of blood plasma that contains antibody. IVIg is a blood product which is administered intravenously. It contains polyvalent IgG antibodies which are extracted from the plasma of more than thousand of blood donors. Individuals who are unable to produce adequate amount of antibodies, such as patients with common variable immunodeficiency, Wiskott Aldrich Syndrome, X-linked agammaglobulinemia and other forms of hypogammaglobulinemia, get benefit from
Intravenous Immunoglobulin (IVIg) Market Professional Survey Report
The term “immunoglobulin” refers to the breakdown of blood plasma that contains antibody. IVIg is a blood product which is administered intravenously. It contains polyvalent IgG antibodies which are extracted from the plasma of more than thousand of blood donors. Individuals who are unable to produce adequate amount of antibodies, such as patients with common variable immunodeficiency, Wiskott Aldrich Syndrome, X-linked agammaglobulinemia and other forms of hypogammaglobulinemia, get benefit from
Immunoglobulin Products Market Forecast 2017-2025 Explored In Latest Research
Immunoglobulin’s also called as antibodies are large Y-shaped protein produced by B-cell.  These are the glycoprotein molecule produced by plasma cells in response to entry of foreign entity such as bacteria and viruses in the body. Production of antibodies is an important function of immune system. Antibodies use binding mechanism for neutralizing the activity of a foreign particle called as an antigen. These are made up of basic structural unit’s
Intravenous Immunoglobulin Market Analysis & Trends 2024
Transparency Market Research estimates that the global intravenous immunoglobulin (IVIG) market, which was valued at US$7.23 bn in 2015, is projected to expand at a CAGR of 8.5% from 2016 to 2024 and reach US$14.92 bn in 2024. In terms of end users, the hospitals segment is presently leading, accounting for a more than 62% of the overall market in 2015. The segment is, however, expected to lose prominence to
Global Subcutaneous Immunoglobulin Market | MarketResearchReports.biz
Latest industry research report on: Global Subcutaneous Immunoglobulin Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Global Subcutaneous Immunoglobulin Market: Overview Primary humoral immunodeficiency or primary immune deficiency diseases (PIDD) is a group of disorders in which the immune system of an individual does not function properly. In PIDD patients, the number of antibodies produced in the body is not sufficient, or the ones produced are